Jacob Haaber Christensen

Jacob Haaber Christensen is a Physician Scientist at the University of Southern Denmark's Faculty of Health Sciences, Department of Clinical Research, and works at Odense University Hospital in the Research unit of Haematology. His research focuses on hematological malignancies, particularly lymphoma treatments and clinical trials.

Dr. Christensen's primary research interests include

• Mantle Cell Lymphoma
• B-Cell and T-Cell Immunology
• Novel Therapies including Brentuximab Vedotin and Bispecific Antibodies
• Progression and Overall Survival metrics
• Cardiovascular risks in lymphoma patients

His recent publications demonstrate expertise in clinical trial analysis, particularly the ECHELON-2 study and Nordic Lymphoma Group trials. His work spans both experimental therapeutics and real-world population-based studies in Denmark.

Dr. Christensen has been active in establishing a Phase I unit in Odense, as reported in Danish media in mid-2024. His research output includes 135 publications with significant focus on lymphoma treatment outcomes.